Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion

Copyright © 2012 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 145(2012), 3 vom: 14. Dez., Seite 189-200
1. Verfasser: Berthet, Julien (VerfasserIn)
Weitere Verfasser: Damien, Pauline, Hamzeh-Cognasse, Hind, Arthaud, Charles-Antoine, Eyraud, Marie-Ange, Zéni, Fabrice, Pozzetto, Bruno, McNicol, Archibald, Garraud, Olivier, Cognasse, Fabrice
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Comparative Study Journal Article Research Support, Non-U.S. Gov't CD63 protein, human CXCL8 protein, human Cytokines IL6 protein, human Interleukin-6 Interleukin-8 Lipopolysaccharide Receptors mehr... Lipopolysaccharides P-Selectin Protein Isoforms SELP protein, human TLR4 protein, human Tetraspanin 30 Toll-Like Receptor 4 Tumor Necrosis Factor-alpha
LEADER 01000naa a22002652 4500
001 NLM222201142
003 DE-627
005 20231224053721.0
007 cr uuu---uuuuu
008 231224s2012 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2012.09.004  |2 doi 
028 5 2 |a pubmed24n0740.xml 
035 |a (DE-627)NLM222201142 
035 |a (NLM)23108090 
035 |a (PII)S1521-6616(12)00229-X 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Berthet, Julien  |e verfasserin  |4 aut 
245 1 0 |a Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 17.01.2013 
500 |a Date Revised 16.08.2019 
500 |a published: Print-Electronic 
500 |a CommentIn: Clin Immunol. 2013 Jan;146(1):13-4. - PMID 23168607 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2012 Elsevier Inc. All rights reserved. 
520 |a Platelets are currently acknowledged as cells of innate immunity and inflammation and play a complex role in sepsis. We examined whether different types of LPS have different effects on the release of soluble signaling/effective molecules from platelets. We used platelet-rich plasma from healthy volunteers and LPS from two strains of gram-negative bacteria with disparate LPS structures. We combined LPS-stimulated platelet supernatants with reporter cells and measured the PBMC cytokine secretion profiles. Upon stimulation of platelets with both Escherichia coli O111 and Salmonella minnesota LPS, the platelet LPS::TLR4 interaction activated pathways to trigger the production of a large number of molecules. The different platelet supernatants caused differential PBMC secretion of IL-6, TNFα, and IL-8. Our data demonstrate that platelets have the capacity to sense external signals differentially through a single type of pathogen recognition receptor and adjust the innate immune response appropriately for pathogens exhibiting different types of 'danger' signals 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a CD63 protein, human  |2 NLM 
650 7 |a CXCL8 protein, human  |2 NLM 
650 7 |a Cytokines  |2 NLM 
650 7 |a IL6 protein, human  |2 NLM 
650 7 |a Interleukin-6  |2 NLM 
650 7 |a Interleukin-8  |2 NLM 
650 7 |a Lipopolysaccharide Receptors  |2 NLM 
650 7 |a Lipopolysaccharides  |2 NLM 
650 7 |a P-Selectin  |2 NLM 
650 7 |a Protein Isoforms  |2 NLM 
650 7 |a SELP protein, human  |2 NLM 
650 7 |a TLR4 protein, human  |2 NLM 
650 7 |a Tetraspanin 30  |2 NLM 
650 7 |a Toll-Like Receptor 4  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
700 1 |a Damien, Pauline  |e verfasserin  |4 aut 
700 1 |a Hamzeh-Cognasse, Hind  |e verfasserin  |4 aut 
700 1 |a Arthaud, Charles-Antoine  |e verfasserin  |4 aut 
700 1 |a Eyraud, Marie-Ange  |e verfasserin  |4 aut 
700 1 |a Zéni, Fabrice  |e verfasserin  |4 aut 
700 1 |a Pozzetto, Bruno  |e verfasserin  |4 aut 
700 1 |a McNicol, Archibald  |e verfasserin  |4 aut 
700 1 |a Garraud, Olivier  |e verfasserin  |4 aut 
700 1 |a Cognasse, Fabrice  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 145(2012), 3 vom: 14. Dez., Seite 189-200  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:145  |g year:2012  |g number:3  |g day:14  |g month:12  |g pages:189-200 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2012.09.004  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 145  |j 2012  |e 3  |b 14  |c 12  |h 189-200